Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

This funding opportunity supports innovative bioengineering projects that aim to improve healthcare solutions and research methods, particularly in terms of effectiveness, efficiency, and accessibility.

$275,000

Closed

Nationwide

Grant Description

The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

Funding Details

Award Range

Not specified - $275,000

Total Program Funding

Not specified

Number of Awards

Not specified

Matching Requirement

Eligibility

Eligible Applicants

State governments

County governments

City or township governments

Special district governments

Independent school districts

Additional Requirements

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Geographic Eligibility

All

Key Dates

Application Opens

January 11, 2022

Application Closes

December 10, 2024

Contact Information

Grantor

NIH OER Webmaster

OERWebmaster03@od.nih.gov

Subscribe to view contact details

Newsletter Required